Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide
Clinical Trials in Egypt / NCT07022691
Active, not recruiting Observational

The Association Between Abdominal Obesity, Gluteal Muscles Strength and Endurance in Young and Middle-aged Adults.

NCT07022691 · tracked via the Priya Life Science Egypt tracker
Sponsor
Cairo University
Phase
Observational
Started
2024-07-01
Last updated
2025-06-15

Condition(s) studied

Abdominal Obesity in Young and Middle Aged AdultsGluteal Muscles Strength and Endurance

Investigational drug(s) / intervention(s)

Lafayette dynamometer:

Lafayette dynamometer:: Lafayette dynamometer will be used for assessment of muscle strength Flexible tape measurement will be used for assessment of WC and hip circumference.

Study summary

to investigate association between abdominal obesity, gluteal muscles strength and endurance in young and middle-aged adults.

Eligibility

Sex
ALL
Min age
18 Years
Max age
45 Years
Healthy volunteers
Accepted
Inclusion Criteria: Asymptomatic participants of both sexes with age ranges between 18-50 years. The age range of the participants will be chosen since it corresponds to an economically active group in whom movement disorders can greatly impact function and work. Additionally, individuals over 60 years of age may have reduced muscle mass and function (Artaud et al., 2016). Participants with a sedentary lifestyle. - Exclusion Criteria: Pregnancy. an orthopedic disease of the lower limbs. paresthesia or weakness in the lower limb. surgery in the previous years. any other medical conditions affecting lower limb muscle function will be excluded. Smokers. Participants who can't do the tests. Menopause. more than 30 kg/m2. \-

Primary outcome measure(s)

  • assessment of WC and hip circumference. — 1 minute
    Flexible tape measurement will be used
  • assessment of muscle strength. — 3 minutes
    Lafayette dynamometer will be used

Trial sites (1)

FacilityCityRegionStatus
Cairo University Cairo Egypt

More Cairo University trials in Egypt

Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity Enrolling by invitation
Clinical and Radiographic Evaluation of Calcium Hypochlorite Versus Saline As Root Canal Irrigants in Pulpectomy of Primary Molars: a Randomized Clinical Trial Starting soon
Combined Fractional CO₂ Laser and Topical Corticosteroid Versus Topical Corticosteroid Only in the Treatment of Palmoplantar Psoriasis Starting soon
Effect of Breather in COPD Patients With Intermittent Claudication Recruiting
Music Effect on Concentration and Gait in Cerebral Palsy Children During Physical Therapy Sessions Starting soon

Other trials for the same condition

Metabolic Effectiveness of Extracorporeal Shockwave on Abdominal Adiposity Enrolling by invitation
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07022691 on ClinicalTrials.gov ↗ ← All trials in Egypt